Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trillium Asset Management is an active, Boston-based investment management firm specializing in sustainable, responsible, and impact (SRI/ESG) investing. It manages equity and fixed income portfolios for individuals and institutions with a focus on environmental, social, and governance criteria. The company does not develop drugs or health products; it invests in public companies across sectors using ESG screens to drive positive change through shareholder advocacy[1][3][4][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trillium Asset Management.